Biomab EGFR Injection, Strength: 50 mg, Packaging Type: Vial

₹50,000.00 / Vial

Specification

form: Injection
brand: Biomab
strength: 50 mg
pack size: 4 x 10 ml
treatment: Treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer
availability: In Stock
medicine type: Allopathic
packaging type: Vial
manufactured by: Biocon

Add Quantity

Vial

Response within 4 hoursFree to enquire

Description

Biomab EGFR Injection, a humanized monoclonal antibody falls under a class of cancer treatment option known as targeted therapy. Nimotuzumab (Bioamb EGFR) is a chemotherapy drug manufactured by Biocon Limited. It is recommended that Nimotuzumab be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Verify supplier credentials before transacting. Enquiries create leads for the supplier.